Professional Documents
Culture Documents
4A.7 Developing New Drugs
4A.7 Developing New Drugs
The most widely used animals are mice and rat. The number of animals used are kept at a minimum and
the tests used are refined to cause minimum distress. Animals are replaced by tissue cultures and
computer models whenever possible. However, these results are not sufficient enough to move to
testing the drugs on people. So, the law states animal testing should be done first.
Clinical trials are the next stage. Some people are given a placebo.
A placebo is an inactive substance that resembles the drug being tested. This is given as an experimental
control to prevent the possibility of a placebo effect. A placebo effect is when patients appear to
respond to a drug simply because they think it is doing them good.
I. Phase 1: the drug is tested in a small number of healthy volunteers. This is done to see if the
drug works as expected and if it causes any unexpected side effects. At the same time, animal
testing is carried out to observe the long-term effects of the drug.
II. Phase 2: the drug is tested on around 100 – 500 volunteer patients with the target disease. A
similar number of volunteer patients are given a placebo or the best current treatment. These
patients are closely monitored to find out the exact ideal dose, the effectiveness of the drug and
any side effects.
III. Phase 3: before the drug is fully approved, it is tested on thousands of volunteer patients with
the target disease. This is done to confirm the effectiveness and safety of the drug. As the
number of patients are large, there is a higher chance of showing up any adverse side effects
This is done to prevent the placebo effect where patients appear to respond to the drug simply because
they think it will do them good
It is unethical as animals are kept in captivity and they are incapable of giving consent. It is time
consuming an expensive.